Chase-Logeman Funding: How Much Did They Raise & Key Investors

How Much Did Chase-Logeman Raise?
Funding & Key Investors

Chase-Logeman has solidified its market position through a series of strategic capital injections, culminating in a total valuation trajectory represented by $341K. The most recent infusion of $191K marks a significant milestone in the company's operational evolution, underscoring its resilience in the precision manufacturing sector. This late-stage financing serves as a testament to the firm's enduring relevance in high-stakes industrial environments, providing the necessary liquidity to scale production capabilities and refine its specialized machinery portfolio.

By securing this major strategic investment, Chase-Logeman demonstrates a clear commitment to maintaining its competitive edge. The capital allocation strategy reflects a focus on long-term stability and technological advancement, ensuring that the company remains a preferred partner for global pharmaceutical and healthcare entities requiring rigorous, validated filling solutions.

What is Chase-Logeman?

Chase-Logeman

Manufacturing

Industrial Machinery & Equipment

Chase-Logeman Corporation operates as a cornerstone in the precision filling machinery landscape, leveraging over six decades of engineering expertise. The company specializes in the design and manufacture of Monoblock-style equipment, which integrates filling, capping, and labeling into a single, streamlined process. This modular approach is critical for clients in the pharmaceutical, diagnostic, and wellness sectors, where regulatory compliance and equipment longevity are paramount. By prioritizing simplicity and ease of validation, Chase-Logeman has carved out a distinct niche, providing robust, semi-automatic and fully automatic systems that address the complex logistical demands of modern production lines. Their market position is defined by a reputation for reliability, serving as a vital link in the supply chain for high-precision industrial applications.

How much funding has Chase-Logeman raised?

Chase-Logeman has raised a total of $341K across 2 funding rounds:

2020

Debt

$150K

2021

Debt

$191K

Debt (2020): $150K with participation from PPP

Debt (2021): $191K led by PPP

Key Investors in Chase-Logeman

PPP

Public-Private Partnership

What's next for Chase-Logeman?

With the recent influx of capital, Chase-Logeman is well-positioned to accelerate its growth trajectory through targeted R&D and infrastructure optimization. The strategic roadmap likely involves expanding its footprint in the diagnostic and healthcare sectors, where the demand for automated, high-precision filling technology continues to rise. By leveraging this late-stage financing, the company can further enhance its proprietary Monoblock technology, potentially integrating advanced digital monitoring and predictive maintenance features to meet the evolving needs of Industry 4.0. As the firm continues to scale, the focus will remain on maintaining the high quality and validation standards that have defined its legacy, while simultaneously exploring new market segments that require sophisticated, reliable, and scalable filling solutions.

See full Chase-Logeman company page

See More Financial Insights